Global burden of heart failure due to cardiovascular diseases, 1990-2021 and predictions to 2035 based on GBD 2021
Related Experiment Video
Updated: Feb 21, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
Shuang Liu1, Chen Zhang2, Shizhong Cheng1
1Department of Cardiology, The Second Affiliated Hospital of Xuzhou Medical University, 32 Meijian Road, Quanshan District, Xuzhou City, Jiangsu Province 221000, China.
Insights
Heart failure (HF) cases are rising globally, particularly in those over 60. Projections show a substantial increase in HF burden by 2035, highlighting the need for targeted interventions for ischemic heart disease and hypertensive heart disease.
Area of Science:
- Cardiovascular Epidemiology
- Global Health Statistics
- Disease Burden Analysis
Background:
- Heart failure (HF) presents a significant global health challenge.
- Understanding HF epidemiology is crucial for public health strategies.
Purpose of the Study:
- To analyze the epidemiology of heart failure (HF) from 1990 to 2021 using the Global Burden of Disease (GBD) dataset.
- To project the future disease burden of HF up to 2035.
Main Methods:
- Utilized Global Burden of Disease (GBD) 2021 data for HF attributable to cardiovascular diseases (CVDs) from 1990-2021.
- Employed age-period-cohort modeling and Joinpoint regression to analyze trends and effects.
- Applied Bayesian age-period-cohort (BAPC) modeling for future projections of HF patient numbers and age-standardized prevalence rates (ASPR).
Main Results:
- HF risk increases significantly after age 60 and post-2005.
- While HF due to ischemic heart disease (IHD) prevalence is decreasing, hypertensive heart disease (HHD) shows an upward trend in males.
- Global HF cases and years lived with disability (YLDs) more than doubled between 1990 and 2021; projections indicate 27.0 million males and 21.5 million females affected by 2035.
Conclusions:
- The absolute number of HF patients is projected to rise substantially by 2035, indicating a significant CVD-attributable burden.
- Enhanced focus is required on individuals over 60, especially those with IHD and HHD.
- Public health strategies must adapt to the evolving HF landscape.
Background And Aims:
Heart failure (HF) represents a major global health challenge. This study utilized the Global Burden of Disease (GBD) dataset to analyse HF epidemiology from 1990 to 2021 and project disease burden to 2035.
Methods:
We analysed GBD 2021 data on HF attributable to cardiovascular diseases (CVDs) for 1990-2021. Age-period-cohort modelling assessed the effects of age, time period, and birth cohort on HF. Joinpoint regression analysis characterized temporal trends and annual percentage changes (APC) in the age-standardized prevalence rate (ASPR) and years lived with disability (YLDs) for HF due to ischaemic heart disease (IHD) and hypertensive heart disease (HHD). The Bayesian age-period-cohort (BAPC) model projected HF patient numbers and ASPR for 2022-2035.
Results:
Globally, an increased risk of developing HF started at age 60 and after the period 2005-2009. Birth cohorts showed protective factors after 1955-1959. The Joinpoint model suggested that ASPR of HF resulting from IHD gradually decreased since 2019 (APC = -0.74, 95% UI: -0.94 to -0.55, P < .001). HHD showed a continuous upward trend in male patients, while decreasing in females after 2019 (APC = -0.47, 95% UI: -0.74 to -0.20, P < .01). Between 1990 and 2021, CVDs-attributable HF cases and YLDs rose from 20.1 million (95% UI: 17.3-23.4) and 1.92 million (95% UI: 1.28-2.66) to 45.6 million (95% UI: 39.7-52.7) and 4.32 million (95% UI: 2.96-5.94), respectively, representing increases of 127% and 126%. ASPR and age-standardized YLD rates increased by 3.74% and 3.36%. Projections indicate the global HF population will reach 27.0 million (95% UI: 21.6-32.5) males and 21.5 million (95% UI: 16.8-26.3) females by 2035, with stable ASPR.
Conclusions:
The rising absolute number of HF patients indicates a substantial CVD-attributable burden by 2035, necessitating enhanced focus on individuals over 60, particularly those with IHD and HHD.
More Related Videos
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure I: Introduction
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure II: Pathophysiology
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Heart Failure III: Clinical Manifestations